期刊名称:LIVER INTERNATIONAL
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal

Liver International promotes all aspects of the science of hepatology from basic research to applied clinical studies.
Providing an international forum for the publication of high quality original research in hepatology. It is an essential resource for everyone working on normal and abnormal structure and function in the liver and its constituent cells, including clinicians and basic scientists involved in the multi-disciplinary field of hepatology. It also includes studies of pathobiology from experimental models and human material.
Liver International welcomes articles from all fields of hepatology, which may be published as original articles, rapid communications, reviews, and letters to the Editor. Case reports will be accepted if the clinical problem is studied in detail and of sufficient interest in a wider context. Papers are normally evaluated by a peer review process involving at least two independent reviewers. Within the scope of the Journal, articles will be accepted on the basis of scientific quality, originality and up-to-date relevance.
Invited reviews (both mini-reviews and longer definitive articles) will form a regular feature of the journal as will the inclusion of book reviews, editorials and a correspondence column. The editor and publishers will endeavour to keep publication time to a minimum, to make the latest results in the field, rapidly available.
Indexed / Abstracted in
Abstracts in Anthropology (Baywood Publishing) Academic Search (EBSCO) Academic Search Premier (EBSCO) BIOBASE: Current Awareness in Biological Sciences (Elsevier) Biological Abstracts (Thomson ISI) BIOSIS Previews (Thomson ISI) CAB HEALTH (CABI) CABDirect (CABI) CSA Biological Sciences Database (CSA/CIG) Current Contents (Thomson ISI) Current Contents: Clinical Medicine (Thomson ISI) Current Contents: Life Sciences (Thomson ISI) EMBASE (Elsevier) IBIDS: International Bibliographic Information on Dietary Supplements Index Medicus/MEDLINE (NLM) Journal Citation Reports/Science Edition (Thomson ISI) MEDLINE/PubMed (NLM) Review of Medical and Veterinary Mycology Science Citation Index (Thomson ISI) Science Citation Index Expanded (also known as SciSearch) Soybean Abstracts Online (CABI)
Instructions to Authors
Manuscripts, including tables and figures, should be submitted online at: ScholarOne Manuscripts (formerly known as Manuscript Central) http://mc.manuscriptcentral.com/liverint
Page charges - Any article that exceeds 9 printed pages will be charged. (Updated: 17 September 2010) Excess pages must be paid for at a rate of GBP 100 per page unless specific written arrangements have been negotiated with the Editor-in-Chief. Invited papers are as a rule not charged for excess pages. Papers will be invoiced upon publication.
Copyright - At the time of acceptance authors are required to complete a Copyright Transfer Agreement: www.wiley.com/go/ctaaglobal. This must be scanned and sent by e-mail to the Editorial Office: e-mail: liverint@ucalgary.ca. Alternatively, please send it by ground post or by fax to:
Dr Hongqun Liu, Editorial Manager Liver International 1810 HSC 3330 Hospital Dr. NW Calgary AB T2N 4N1 Canada
Fax: +1 403 270 0995
The work shall not be published elsewhere in any language without the written consent of the publisher. The articles published in this journal are protected by copyright, which covers translation rights and the exclusive right to reproduce and distribute all of the articles printed in the journal. No material published in the journal may be stored on microfilm or videocassettes or in electronic databases and the like or reproduced photographically without the prior written permission of Wiley.
As a general rule, papers will be evaluated by two independent reviewers. One copy of the manuscript will be kept in the editorial office in case revision is recommended. Revised manuscripts should be accompanied by a point-by-point reply to the recommendations of reviewers and editor, specifying the changes made in the revised version.
The journal does not hold itself responsible for loss or damage to mailed manuscripts, or for statements made by contributors. Rapid Communications will be considered for important scientific contributions; authors should explain in their accompanying letter why they intend to publish their paper as a rapid communication. Such papers, submitted in quadruplicate, should not exceed seven manuscript pages, including no more than 2 tables, 2 figures and 12 references.
Online Open - OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms.
Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at: https://secure.interscience.wiley.com/funded_access.html Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
Manuscripts - The following rules are in general agreement with Uniform requirements for manuscripts submitted to biomedical journals accepted by an International Steering Committee (see ref. 1 below). The paper should be submitted in English. Begin each manuscript component (title page, etc.) on separate pages. The pages of the manuscript text, reference list, tables and legends to figures, in that order, should be numbered consecutively.
Title page - The title page should contain: 1. a concise informative title; 2. author(s)'s names; 3. Name of department(s) / institutions to which the work is attributed; 4. name, address, telephone (and telefax) number of the author to whom correspondence about the manuscript, and requests for offprints should be referred; 5. separate word counts for the abstract and main text (excluding acknowledgements, legends, tables and references); 6. if the title exceeds 40 characters (letters and spaces), a running head of no more, than 40 characters.
Abstract and keywords - The abstract must not exceed 250 words. It should be structured under five subheadings: Background, Aims, Methods, Results and Conclusions. Below the abstract, provide 3-10 key words or short phrases that will assist indexers in cross-indexing your article. Use terms from the Medical Subject Headings list from Index Medicus, whenever possible. Please note that clear, descriptive and search-optimized titles and abstracts are important considerations to the journal. Guidelines available at http://www.blackwellpublishing.com/bauthor/seo.asp
Introduction - Present the background briefly, but do not review the subject extensively. Give only pertinent references. State the specific questions you want to answer.
Patients and methods / Material and methods - Describe selection of patients or experimental animals, including controls. Do not use patients' names or hospital numbers. Identity methods, apparatus (manufacturer's name and address), and procedures in sufficient detail to allow other workers to reproduce the results. Provide references and brief descriptions of methods that have been published. When using new methods, evaluate their advantages and limitations. Identify drugs and chemicals, including generic name, dosage and route(s) of administration. Authors must indicate that the procedures were approved by the Ethical Committee of Human Experimentation in their country, and are in accordance with the Helsinki Declaration of 1975. All papers reporting experiments using animals must include a statement in the Material and Methods section giving assurance that all animals received humane care.
The authors accept full responsibility for the accuracy of the whole content, including findings, citations, quotations and references contained in the manuscript.
Registration of Clinical Trials - The International Committee of Medical Journal Editors (ICJME) has established a requirement that all clinical trials be entered in a public registry (see e.g. ClinicalTrial.gov) before the onset of patient enrolment, as a condition of consideration for publication. Liver International endorses that policy.
Results - Present results in logical sequence in tables and illustrations. In the text, explain, emphasise or summarise the most important observations. Units of measurement should be expressed in accordance with Systéme International d'Unités (SI Units).
Discussion - Do not repeat in detail data given in the Results section. Emphasise the new and important aspects of the study. Relate the observations to other relevant studies. On the basis of your findings (and others') discuss possible implications/conclusions. When stating a new hypothesis, clearly label it as such.
Acknowledgements - Acknowledge only persons who have made substantive contributions to the study. Authors are responsible for obtaining written permission from everyone acknowledged by name because readers may infer their endorsement of the data and conclusions.
Tables - Tables should be numbered consecutively with Arabic numerals. Type each table on a separate sheet, with titles making them self-explanatory. The authors may recommend that additional tables containing important backup data be deposited with the National Auxiliary Publications Service or other permanent organisations. Such a deposition should be noted in the text.
Illustrations - Images included in online submissions are for review purposes only, and should be suitable for online viewing. Please provide best quality figures with final accepted manuscripts. Digital files in accordance with our instructions at http://authorservices.wiley.com/prep_illust.asp can be used by production. EPS (illustrations, graphs, annotated artwork; minimum resolution 800 dpi) and TIFF (micrographs, photographs; minimum resolutions 300 dpi) are recommended, although in some cases other formats can be used. Files should be at print size.
It is in the interest of authors to follow the guidelines below, as this would lessen the risk of errors in redrawing/correction and also reduce both the time and costs of manuscript preparation.
Figures submitted should be of a size suitable to withstand 50% reduction for either a single column of 77 mm width or a double column of 159 mm width.
Legends - Each figure should have a legend containing sufficient information to make the figure intelligible without reference to the text. Legends should be typed double-spaced in consecutive order on a separate page. They should be brief and specific. If micrographs are used, information about staining methods and magnification should be given.
In the full text online edition of the journal, figure legends may be truncated in abbreviated links to the full screen version. Therefore the first 100 characters of any legend should inform the reader of key aspects of the figure. Figures should ideally be EPS (line art) or TIFF (photographs) files.
Colour - It is the policy of Liver International for authors to pay the full cost for the reproduction of their colour artwork. Therefore, please note that if there is colour artwork in your manuscript when it is accepted for publication, Wiley-Blackwell require you to complete and return a colour work agreement form before your paper can be published. This form can be downloaded as a PDF at http://www.blackwellpublishing.com/pdf/sN_Sub2000_X_CoW.pdf. Any article received by Wiley-Blackwell with colour work will not be published until this form has been returned*.
*Exemptions include commissioned reviews and 'Liver International Images'. Also, the authors of a paper whose artwork is selected for publication on the front cover of the Journal are exempt from colour work charges for that paper.
Please return your completed form to:
Valerie Oliveiro, Production Editor Liver International, Wiley-Blackwell Wiley Services Singapore Pte Ltd 600 North Bridge Road #05-01 Parkview Square Singapore 188778 Fax: +65 6811 8288 Email: liv@wiley.com
Abbreviations, symbols and nomenclature - should be standardised and in accordance with ELLIS G (ed.). Units, symbols and abbreviations. The Royal Society of Medicine, 1 Wimpole Street, London Wl M 8AE, 1975.
References -
We recommend the use of a tool such as EndNote or Reference Manager for reference management and formatting. EndNote reference styles can be searched for here: http://www.endnote.com/support/enstyles.asp. Reference Manager reference styles can be searched for here: http://www.refman.com/support/rmstyles.asp.
Number references consecutively in the order in which they are first mentioned in the text. Identify references in text, tables and legends by Arabic numerals (in parentheses). All references cited, and only these, must be listed at the end of the paper. References should be according to the style used in Index Medicus and International list of periodical title word abbreviations (ISO 833). Examples: 1 . International Steering Committee. Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 1997; 336 (4) 309. 2. Luscombe C, Pedersen J, Bowden S, Locarini S. Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapy. Liver 1994; 14: 182-92. 3. Gines A, Salmeron J M, Gines P, et al. Effects of somalostatin on renal function in cirrhosis. Gastroenterology 1992; 103: 1868-84. 4. Demetris A J, Kakizoe S, Oguma S. Pathology of liver transplantation. In: Williams K W ed. Hapatic transplantation. Philadelphia: WB Saunders Co., 1990: 60-113.
5. List all authors up to six. If six or more authors, list the first three followed by 'et al.'
Manuscript types:
Original Research - Liver International publishes both clinical and experimental laboratory ('basic') research in all aspects of normal and abnormal liver function and disease.
Case Reports - will only be considered if they illustrate novel mechanisms of disease pathogenesis. Case reports that fail to meet this condition will not be accepted, no matter how interesting or unusual.
Letters - two types of letters will be considered: i) Correspondence concerning papers published in Liver International should be less than 400 words, with a maximum of 8 references and 4 authors; ii) Short reports of original research or case descriptions should have a maximum of 600 words, 8 references and 1 figure or table. There is no limit on the number of authors for this type of letter.
Reviews - are generally commissioned by the Editors. While unsolicited reviews will be considered, authors are encouraged to contact the Editor-in-Chief or an Associate Editor before submitting a review. The use of figures and illustrations to aid readability is encouraged.
Liver International Images - interesting or arresting images, either clinical or experimental, should be accompanied by a brief explanation of no more than 250 words, with a maximum of 4 references and 4 authors. Colour charges will be waived for these articles.
Editorials and Debates - both article types are commissioned by the Editors. They should be limited to 1500 words and 20 references.
Liver International News - are commissioned by the Editors.
Proofs - When proofs are ready for checking, the corresponding author will receive an email alert containing a link to a web site. A working e-mail address must therefore be provided for the corresponding author. The proof can be downloaded as a PDF (portable document format) file from this site. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following web site: http://www.adobe.com/products/acrobat/readstep2.html. This will enable the file to be opened, read and corrected on screen. Further instructions will be sent with the proof. Hard copy proofs will be posted if no e-mail address is available. Excessive changes made by the author in the proofs, excluding typesetting errors, will be charged separately.
Offprints - Additional offprints may be ordered on the offprint order form which will be sent with the proof.
Early View - Liver International is covered by Wiley-Blackwell's Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles mean that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at www.blackwellpublishing.com.
Author material archive policy - Please note that unless specifically requested, Wiley-Blackwell will dispose of all hardcopy or electronic material submitted 2 months after publication. If you require the return of any material submitted, please inform the editorial office or production editor as soon as possible if you have not yet done so.
Disclaimer - The Publisher, the International Association for the Study of the Liver and the Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; the views and opinions expressed do not necessarily reflect those of the Publisher, the International Association for the Study of the Liver and the Editors; neither does the publication of advertisements constitute any endorsement by the Publisher, the International Association for the Study of the Liver and the Editors of the products advertised.
Author Services. Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit www.blackwellpublishing.com/bauthor for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Note to NIH Grantees
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate.
Editorial Board
EDITOR-IN-CHIEF
Samuel S. Lee, Canada
Editorial Manager/Editorial Office Hongqun Liu, Liver International Rm 1810 Health Sciences Centre 3330 Hospital Dr NW Calgary, AB, T2N 4N1 Canada Tel: +1 403 220 7370 Fax: +1 403 270 0995 Email: Liver.Int@ucalgary.ca
ASSOCIATE EDITORS
Africa/Middle East Sanaa Kamal, Egypt Cihan Yurdaydin, Turkey
Asia-Pacific Han-Chieh Lin, Taiwan Irene O. Ng, Hong Kong Shuichi Kaneko, Japan Young-Hwa Chung, South Korea
Europe Paul Calès, France Peter Ferenci, Austria Peter Fickert, Austria Francesco Negro, Switzerland
North America Stephen H. Caldwell, USA Hartmut Jaeschke, USA Jenny Heathcote, Canada Don Rockey, USA
South America Marco Arrese, Chile Adrian Gadano, Argentina
Editorial Board liv_edbd.pdf
|